Generates GDPR Article 30(1) RoPA for data controllers with all 7 mandatory fields including Python automation script. Useful for compliance, processing records, data mapping.
npx claudepluginhub mukul975/privacy-data-protection-skills --plugin privacy-skills-completeThis skill uses the workspace's default tool permissions.
GDPR Article 30(1) requires every controller to maintain a written record of processing activities carried out under its responsibility. This skill provides a complete methodology for creating controller RoPA entries that satisfy all seven mandatory field requirements specified in Art. 30(1)(a) through (g), ensuring the organisation can demonstrate accountability under Art. 5(2) and respond to ...
Conducts multi-round deep research on GitHub repos via API and web searches, generating markdown reports with executive summaries, timelines, metrics, and Mermaid diagrams.
Dynamically discovers and combines enabled skills into cohesive, unexpected delightful experiences like interactive HTML or themed artifacts. Activates on 'surprise me', inspiration, or boredom cues.
Generates images from structured JSON prompts via Python script execution. Supports reference images and aspect ratios for characters, scenes, products, visuals.
GDPR Article 30(1) requires every controller to maintain a written record of processing activities carried out under its responsibility. This skill provides a complete methodology for creating controller RoPA entries that satisfy all seven mandatory field requirements specified in Art. 30(1)(a) through (g), ensuring the organisation can demonstrate accountability under Art. 5(2) and respond to supervisory authority requests under Art. 30(4).
This field must identify:
Example for Helix Biotech Solutions:
| Sub-field | Value |
|---|---|
| Legal entity name | Helix Biotech Solutions GmbH |
| Registered address | Leopoldstraße 42, 80802 Munich, Germany |
| Registration | HRB 267891, Amtsgericht Munich |
| Contact email | privacy@helix-biotech.eu |
| DPO | Dr. Elena Voss, dpo@helix-biotech.eu, +49 89 7654 3210 |
| EU Representative | Not applicable (established in EEA) |
| Joint controllers | None for this processing activity |
Each processing activity must have one or more specific, explicit, and legitimate purposes documented. Purposes must be granular enough to demonstrate compliance with the purpose limitation principle under Art. 5(1)(b).
Avoid vague purposes such as:
Acceptable purpose examples:
| Processing Activity | Purpose Statement | Lawful Basis Reference |
|---|---|---|
| Employee payroll | Calculation and disbursement of monthly salaries and statutory deductions under employment contract obligation | Art. 6(1)(b) — contract performance |
| Clinical trial data collection | Recording of participant vital signs, adverse events, and treatment outcomes for Phase III oncology trial protocol HBX-2025-ONC-04 | Art. 6(1)(a) — explicit consent; Art. 9(2)(a) — explicit consent for health data |
| Customer account management | Maintaining customer identity, contact, and billing records to fulfil supply agreements for laboratory reagent orders | Art. 6(1)(b) — contract performance |
| Pharmacovigilance reporting | Collection and assessment of adverse drug reaction reports for submission to EMA under EU Regulation 726/2004 | Art. 6(1)(c) — legal obligation |
Identify all groups of individuals whose personal data is processed within each activity. Be exhaustive; omitting a data subject category creates a compliance gap.
Common categories for a biotech organisation:
For each processing activity, specify the types of personal data collected and processed. Flag special category data under Art. 9(1) and criminal conviction data under Art. 10.
Example data categories by processing activity:
| Processing Activity | Personal Data Categories | Special Category (Art. 9) |
|---|---|---|
| Employee payroll | Name, employee ID, bank account (IBAN), tax ID, salary grade, working hours | No |
| Clinical trial management | Participant ID, date of birth, sex, medical history, genetic markers, treatment allocation, adverse events | Yes — health data, genetic data |
| Pharmacovigilance | Reporter name, patient initials, age, diagnosis, medication history, adverse reaction description | Yes — health data |
| Visitor management | Name, company affiliation, photo ID, visit date/time, host employee | No |
Document all entities that receive personal data, including:
Example:
| Recipient | Type | DPA/Agreement Reference |
|---|---|---|
| SAP SuccessFactors (SAP SE) | Processor | DPA-2024-SAP-001, executed 2024-02-15 |
| ADP Employer Services GmbH | Processor | DPA-2023-ADP-002, executed 2023-09-01 |
| Finanzamt Munich | Public authority | Section 93 AO — tax reporting obligation |
| AOK Bayern | Other controller | Statutory health insurance reporting under SGB V |
| Helix Biotech Solutions Ltd (UK subsidiary) | Intra-group controller | Art. 26 joint controller arrangement, ref: JCA-2024-UK-001 |
Record every transfer of personal data to a third country (outside the EEA) or international organisation. For each transfer, document:
Example:
| Destination | Recipient | Mechanism | TIA Reference |
|---|---|---|---|
| United States | Veeva Systems Inc. | EU-US Data Privacy Framework adequacy decision (10 July 2023) — Veeva listed on DPF List | TIA-2024-VEEVA-001 |
| United Kingdom | Helix Biotech Solutions Ltd | UK adequacy decision (28 June 2021, extended) | Not required (adequacy) |
| India | Wipro Ltd (IT support) | EU SCCs Module 2 (controller-to-processor), executed 2024-06-01 | TIA-2024-WIPRO-003 |
Specify the envisaged time limits for erasure of each category of data, or the criteria used to determine the retention period. Periods must be concrete and objectively determinable.
Example retention schedule:
| Data Category | Retention Period | Legal Basis for Retention | Deletion Method |
|---|---|---|---|
| Employee payroll records | 10 years from end of employment | Section 257 HGB, Section 147 AO | Automated deletion from SAP HCM |
| Clinical trial data | 25 years from trial completion | Section 13(10) GCP-V; ICH E6(R2) | Archived then destroyed per SOP-DM-012 |
| Job applicant data | 6 months from hiring decision | AGG limitation period | Automated purge from ATS |
| Website analytics | 14 months from collection | CNIL recommendation on analytics retention | GA4 automatic data expiration |
| CCTV footage | 72 hours rolling | Proportionality assessment (DPO approved) | Automated overwrite on NVR |
While not a numbered "field" in the same sense, Art. 30(1)(g) requires a general description of Art. 32 technical and organisational security measures. This description should be meaningful without revealing specific vulnerabilities.
Example:
Technical measures: AES-256 encryption at rest for all databases containing personal data; TLS 1.3 for data in transit; role-based access control (RBAC) with quarterly access reviews; multi-factor authentication for all systems processing personal data; daily encrypted backups with 30-day retention; network segmentation isolating clinical trial systems from corporate IT; endpoint detection and response (EDR) on all workstations; annual penetration testing by independent assessor.
Organisational measures: Mandatory data protection training for all employees (annual refresher); background checks for employees with access to special category data; clean desk policy; data classification scheme (Public, Internal, Confidential, Restricted); incident response procedure with 4-hour initial assessment SLA; vendor security assessments prior to engagement; ISO 27001:2022 certified ISMS (certificate ref: IS 782341).
Identify the processing activity: Start with a specific processing activity, not a department or system. One system may support multiple processing activities, each requiring its own RoPA entry.
Interview the processing owner: Conduct a structured interview covering all seven fields. Use the data flow as the narrative: "Data comes from [source] about [data subjects], containing [data categories], for the purpose of [purpose], shared with [recipients], transferred to [countries], kept for [duration], protected by [measures]."
Validate against source systems: Cross-reference interview responses with actual system configurations, data flow diagrams, and contractual documents.
Draft the RoPA entry: Populate all seven fields using the templates and examples above.
Review with DPO: The DPO reviews the entry for legal accuracy, particularly the purpose description, lawful basis alignment, and transfer mechanism adequacy.
Obtain processing owner sign-off: The business owner confirms factual accuracy of the data flows, recipients, and retention periods.
Register in the RoPA management system: Enter the validated record into the organisation's RoPA tool (e.g., OneTrust, TrustArc, or structured spreadsheet).
Set review date: Schedule the next review no later than 12 months from creation, or earlier if the processing activity is high-risk.
Department-level records instead of activity-level: A single "HR" record covering all HR processing is non-compliant. Each distinct processing activity (payroll, recruitment, performance management, time tracking) requires its own entry.
Missing processor chain documentation: When a processor engages sub-processors, the RoPA must reflect the entire processing chain, not just the primary processor.
Conflating controller and processor roles: Where the organisation acts as both controller (for its own processing) and processor (for client data), separate RoPA entries under Art. 30(1) and Art. 30(2) are required.
Ignoring informal processing: Spreadsheet-based processing, shared drives, and email-based data handling are processing activities that require RoPA entries.
Static retention periods for dynamic data: Different data elements within the same processing activity may have different retention periods (e.g., contract data vs. marketing preferences collected during onboarding).